Nevirapine 50mg disp. tabs/PAC-30

NOTE: The description below is for a standard product. It is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: supply@unicef.org

General Description:
Nevirapine 50mg dispersible tablets, bottle pack of 30

Technical Specifications:
Each dispersible tablet contains Nevirapine 50mg calculated on the anhydrous basis.
Tablets are used to prepare an oral suspension

Therapeutic class:
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)

Standard shelf life:
24 months

Other available formulations:
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use:
For more details, please click the links listed below:

WHO treatment guidelines


and

WHO Essential Medicines Library


or your regional national guidelines

For details about paediatric dosage schemes, please click the links listed below:

WHO HIV/AIDS


WHO Generic tool for assessing paediatric ARV dosing


Indications:
Management of HIV infection in combination with at least two other antiretroviral drugs. By mouth (oral), PO.
Prevention of mother-to-child transmission in HIV-infected patients

Storage:
Do not store above 30ºC (86ºF).
Store in a tightly closed container
Keep out of reach and sight of children.

Dispensing instructions:
Dispense in original container. Do not repack
Tablets are to be dispersed in about 5ml water immediately before administration

Regulatory Status:
For latest updates, please click the links listed below:

List of WHO Prequalified Medicines


List of USFDA approved and tentatively approved items